Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 19, 2024Antiviral ResearchOpen Access

Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles – A recombinant vaccine candidate

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMarta ZimnaGBGabriela BrzuskaJSJiřı́ Salát

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zimna et al. (2024) studied this question.

synapsesocial.com/papers/68e6417fb6db6435875d30cehttps://doi.org/10.1016/j.antiviral.2024.105941
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8 + T-cell responses: The immunological consequences of the biodistribution profile2016 · 82 citations
  2. 2Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine2011 · 75 citations
  3. 3Biochemistry and Molecular Biology of Flaviviruses2018 · 363 citations
  4. 4Construction and application of chimeric virus-like particles of tick-borne encephalitis virus and mosquito-borne Japanese encephalitis virus2007 · 33 citations
  5. 5The Role of Antibody Concentration and Avidity in Antiviral Protection1997 · 275 citations